|
86
|
347
|
3w55A |
The structure of erk2 in complex with fr148083 |
|
98
|
361
|
3vumA |
Crystal structure of a cysteine-deficient mutant m7 in map kinase jnk1 |
|
104
|
359
|
3vugA |
Crystal structure of a cysteine-deficient mutant m2 in map kinase jnk1 |
|
95
|
358
|
3vulA |
Crystal structure of a cysteine-deficient mutant m1 in map kinase jnk1 |
|
104
|
358
|
3vukA |
Crystal structure of a cysteine-deficient mutant m5 in map kinase jnk1 |
|
94
|
358
|
3vudA |
Crystal structure of a cysteine-deficient mutant m1 in map kinase jnk1 |
|
108
|
358
|
3vuhA |
Crystal structure of a cysteine-deficient mutant m3 in map kinase jnk1 |
|
97
|
357
|
3v3vA |
Structural and functional analysis of quercetagetin, a natural jnk1 inhibitor |
|
105
|
357
|
3v6sA |
Discovery of potent and selective covalent inhibitors of jnk |
|
102
|
357
|
3v6rA |
Discovery of potent and selective covalent inhibitors of jnk |
|
106
|
348
|
3uvpA |
Human p38 map kinase in complex with a benzamide substituted benzosuberone |
|
104
|
349
|
3uvqA |
Human p38 map kinase in complex with a dibenzosuberone derivative |
|
116
|
347
|
3uvrA |
Human p38 map kinase in complex with km064 |
|
112
|
355
|
3ttjA |
Crystal structure of jnk3 complexed with cc-359, a jnk inhibitor for the prevention of ischemia-reperfusion injury |
|
111
|
349
|
3u8wA |
Crystal structure of p38a mitogen-activated protein kinase in complex with a triazolopyridazinone inhibitor |
|
107
|
355
|
3ttiA |
Crystal structure of jnk3 complexed with cc-930, an orally active anti-fibrotic jnk inhibitor |
|
92
|
348
|
3tg1A |
Crystal structure of p38alpha in complex with a mapk docking partner |
|
101
|
349
|
3teiA |
Crystal structure of human erk2 complexed with a mapk docking peptide |
|
85
|
349
|
3s4qA |
P38 alpha kinase complexed with a pyrazolo-triazine based inhibitor |
|
104
|
349
|
3s3iA |
P38 kinase crystal structure in complex with small molecule inhibitor |
|
96
|
355
|
3rtpA |
Design and synthesis of brain penetrant selective jnk inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration |
|
110
|
348
|
3rocA |
Crystal structure of human p38 alpha complexed with a pyrimidinone compound |
|
117
|
406
|
3rp9A |
Crystal structure of the apo mapk from toxoplasma gondii, 25.m01780 or tgme49_007820 |
|
110
|
349
|
3rinA |
P38 kinase crystal structure in complex with small molecule inhibitor |
|
108
|
348
|
5wjjA |
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 map kinase inhibitors |
|
110
|
343
|
5wp1A |
Complex of erk2 with 5,7-dihydroxychromone |
|
116
|
351
|
5v62A |
Phospho-erk2 bound to bivalent inhibitor sbp3 |
|
113
|
349
|
5v60A |
Phospho-erk2 bound to amp-pcp |
|
115
|
350
|
5v61A |
Phospho-erk2 bound to bivalent inhibitor sbp2 |
|
109
|
351
|
5umoA |
Structure of extracellular signal-regulated kinase |
|
107
|
349
|
5uojA |
The structure of the map kinase p38 at 2.1 angstroms resolution |
|
114
|
340
|
5u6iA |
Discovery of mli-2, an orally available and selective lrrk2 inhibitor that reduces brain kinase activity |
|
101
|
349
|
5tbeA |
Human p38alpha map kinase in complex with dibenzosuberone compound 2 |
|
107
|
347
|
5tcoA |
Human p38 map kinase in complex with dibenzosuberone compound 1 |
|
107
|
348
|
5o8uA |
Covalent inhibitor 4b bound to the lipid pocket of p38alpha mutant s252c |
|
106
|
350
|
5o8vA |
Covalent inhibitor 4a bound to the lipid pocket of p38alpha mutant s251c |
|
112
|
340
|
5o7iA |
Erk5 in complex with a pyrrole inhibitor |
|
93
|
349
|
5o90A |
Crystal structure of a p38alpha t185g mutant in complex with tab1 peptide. |
|
102
|
350
|
5nzzE |
Crystal structure of phosphorylated p38amapk in complex with tab1 |
|
113
|
345
|
5nhjA |
Human erk2 with an erk1/2 inhibitor |
|
110
|
345
|
5nhoA |
Human erk2 with an erk1/2 inhibitor |
|
109
|
349
|
5n67A |
Crystal structure of p38alpha in complex with lipid pocket ligand 9l |
|
102
|
348
|
5mtyA |
Dibenzosuberone inhibitor 8e in complex with p38 mapk |
|
108
|
348
|
5n68A |
Crystal structure of p38alpha in complex with lipid pocket ligand 9m |
|
109
|
344
|
5nhfA |
Human erk2 with an erk1/2 inhibitor |
|
109
|
348
|
5n66A |
Crystal structure of p38alpha in complex with lipid pocket ligand 9j |
|
101
|
345
|
5nguA |
Human erk2 with an erk1/2 inhibitor |
|
114
|
345
|
5nhpA |
Human erk2 with an erk1/2 inhibitor |
|
103
|
348
|
5ml5A |
Human p38alpha mapk in complex with imidazolyl pyridine inhibitor 11b |
|
120
|
348
|
5byzA |
Erk5 in complex with small molecule |
